Daniel Blumrich

Daniel Blumrich is a highly accomplished professional with a solid background in Biotechnology and Tumor Biology. He holds an M.Sc. in Biotechnology from Ecole Supérieure de Biotechnologie Strasbourg and a PhD in Tumor Biology from DKFZ German Cancer Research Center.

With an extensive work history in the pharmaceutical industry, Daniel has held several key positions. Currently, he serves as the Senior Director and US Marketing Lead for Neuroendocrine Tumors at Advanced Accelerator Applications, which is a subsidiary of Novartis. Prior to this role, he was the Director of Global Marketing Launch Indication Lead for Adakveo (SCD) and the Director of Global Marketing Indication Lead for Myelodysplastic Syndromes at Novartis.

Additionally, Daniel has garnered diverse experience at Novartis, ranging from Sales Manager positions to Brand Manager roles in Oncology, Hematology, and Osteoporosis. He also has experience as a Trainee in Marketing and Sales at Nycomed. Moreover, his academic background includes a Postdoctoral position at DKFZ German Cancer Research Center and a Visiting Researcher role at Stanford University.

Daniel Blumrich's wealth of experience in marketing, sales, and pharmaceutical leadership roles showcases his expertise in the pharmaceutical industry. His educational background in Biotechnology and Tumor Biology complement his professional journey, making him a seasoned professional in the field.